Clinical Trials Directory

Trials / Unknown

UnknownNCT04071132

Using Adhesive Biosensor Patches to Characterize the Biochemical Phenotype in PTSD

Using Adhesive Biosensor Patches to Characterize the Biochemical Phenotype in Individuals Diagnosed With PTSD

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Nadav Goldental · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

A psychiatric diagnosis of post-traumatic stress disorder (PTSD) is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. PTSD has physiological manifestations, some of which are likely reflected in the levels and ratios of certain stress-related proteins in the interstitial fluid and plasma. Discernable patterns of such stress-related proteins may constitute a biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans. The current study is a non-interventional observational study aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD.

Conditions

Timeline

Start date
2019-08-01
Primary completion
2020-04-01
Completion
2020-09-01
First posted
2019-08-28
Last updated
2019-08-28

Source: ClinicalTrials.gov record NCT04071132. Inclusion in this directory is not an endorsement.